MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
convertible notes payable,...
$7,469K
Proceeds from issuance of
common shares
$2,900K
Proceeds from exercise of
warrants
$6K
Net cash provided by
financing activities
$9,209K
Effect of exchange rate
changes on cash and cash...
$2,175K
Canceled cashflow
$1,166K
Net (decrease)
increase in cash and cash...
-$1,254K
Canceled cashflow
$11,384K
Accounts payable and
accrued expenses
$886K
Other non-current
assets
-$2K
Payment of purchase
consideration to related party
$666K
Repayment of convertible
notes payable
$500K
Net cash used in
operating activities
-$12,509K
Canceled cashflow
$888K
Net cash used in
investing activities
-$129K
Loss from
extinguishment of debt
-$4,756K
Depreciation and
amortization
$771K
Loss from issuance of
debt
-$738K
Allowance for credit loss
$311K
Stock-based compensation
for services
$288K
Amortization of debt discount
$277K
Inducement expense
$87K
Amortization of operating
lease right-of-use...
$76K
Subtotal of non-cash
charges
-$7,548K
Net loss
-$3,069K
Prepaid expenses and
other current assets
$2,276K
Canceled cashflow
$7,304K
Related party accounts
payable and accrued...
-$364K
Lease liabilities
-$140K
Purchase of equipment and
construction in progress
$129K
Change in fair value of
derivatives
$9,416K
Change in fair value of
convertible notes
$5,235K
Change in fair value of
share payable
$201K
Back
Back
Cash Flow
NORTHWEST BIOTHERAPEUTICS INC (NWBO)
NORTHWEST BIOTHERAPEUTICS INC (NWBO)
source: myfinsight.com